Table 2 Accuracy of rule set 9 applied to AI system segmentation outputs for determining disease activity over subgroups defined by age, sex, ethnicity and diabetic status.

From: Dual site external validation of artificial intelligence-enabled treatment monitoring for neovascular age-related macular degeneration in England

Characteristic

 

n

TP

TN

FP

FN

Accuracy

95% CI

Age

58–75

130

28

78

20

4

81.5%

74.9–88.2%

 

75–82

130

30

73

23

4

79.2%

72.3–86.2%

 

82–86

131

27

76

24

4

78.6%

71.6–85.6%

 

86–98

130

30

80

17

3

84.6%

78.4–90.8%

Sex

Male

194

41

114

32

7

79.9%

74.3–85.5%

 

Female

327

74

193

52

8

81.7%

77.5–85.8%

Diabetic

Yes

59

11

33

14

1

74.6%

63.5–85.7%

 

No/not known

462

104

274

70

14

81.8%

78.3–85.3%

Ethnicity

White

414

96

235

72

11

80.0%

76.1–83.8%

 

Asian

31

5

22

3

1

87.1%

75.4–98.9%

 

Other

39

4

27

6

2

79.5%

66.8–92.2%

 

Unknown

38

10

23

3

2

86.8%

76.1–97.6%

  1. TP True positive, TN True negative, FP False positive, FN False negative, CI Confidence interval.